Mar 8, 2023, 12:16 by Molly McGrath

On March 6th, the Oregon Society of Addiction Medicine (ORSAM) sent a letter to the Senate Committee on Health Care in support of HB 2395-A.

Mar 8, 2023, 10:15 by ASAM Weekly Editors

Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotine

Mar 8, 2023, 09:31 by Maciek Gregorski

The ASAM 54th Annual Conference will showcase best practices and the latest science, research, and innovations from leading experts in the field. Developed for healthcare professionals dedicated to increasing access to and improving the quality of addiction treatment.

Mar 8, 2023, 06:00 by Molly McGrath

The American Society of Addiction Medicine (ASAM) and the National Alliance for Medication Assisted Recovery (NAMA Recovery) today applauded Senators Edward Markey (MA) and Rand Paul (KY) and Representatives Donald Norcross (NJ) and Donald Bacon (NE) for introducing the Modernizing Opioid Treatment Access Act (M-OTAA).

Mar 7, 2023, 07:01 by Molly McGrath

On March 6th, ASAM signed onto a letter with other organizations to Congressional Representatives Brad Wenstrup and Lauren Underwood, underscoring support for their legislation to make Veterans Health Administration (VHA) facilities fully smoke-free.

Mar 6, 2023, 06:00 by Molly McGrath

Mar 2, 2023, 08:59 by Molly McGrath

On February 28th, ASAM signed onto a letter with hundreds of organizations to Senators Debbie Stabenow and John Boozeman, Chairwoman and Ranking Member of the Senate Committee on Agriculture, Nutrition, and Forestry, and Representatives Glenn Thompson and David Scott, Chairman and Ranking Member of the House Committee on Agriculture, asking them to remove a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill.

Mar 1, 2023, 10:12 by ASAM Weekly Editors

The Howard Street Method

Feb 28, 2023, 13:15 by Molly McGrath

On February 28th, the Tennessee Society of Addiction Medicine (TNSAM) sent a letter to the House Subcommittee on Criminal Justice in support of HB 309/SB 1072. This bill would decriminalize possession of personal use quantities of cannabis (1 ounce or less).

Feb 22, 2023, 15:55 by Molly McGrath

On February 17th, the Utah Society of Addiction Medicine (UTSAM) sent a letter to Governor Spencer Cox urging him to sign SB 86 into law.

Feb 22, 2023, 09:53 by ASAM Weekly Editors

The Use of Opioids in the Management of Chronic Pain.

Feb 15, 2023, 14:57 by ASAM Weekly Editors

State Cannabis Legalization and Psychosis.

Feb 14, 2023, 09:08 by Bob Davis

The American Society of Addiction Medicine (ASAM) celebrates the release of The ASAM Criteria Implementation Guide, a practical approach for treatment programs and systems of care to integrate The ASAM Criteria® into clinical operations, to improve quality of care in manageable increments, and to find a balance between fidelity to standards and flexibility to meet the needs of patients.

Feb 13, 2023, 17:35 by Molly McGrath

On February 12th, ASAM provided comments to SAMHSA on its proposed modifications to medications for the treatment of opioid use disorder (OUD) in 42 C.F.R. Part 8.

Feb 10, 2023, 08:00 by Molly McGrath

On February 10th, ASAM provided comments to the Centers for Medicare and Medicaid Services (CMS) applauding the Biden-Harris Administration’s focus on addressing our nation’s critical addiction treatment needs, including through the CMS Behavioral Health Strategy.

Feb 9, 2023, 09:58 by Molly McGrath

On February 9th, ASAM submitted comments to the Centers for Medicare and Medicaid Services (CMS) on its proposed rule regarding changes to the Medicare Advantage (MA) program for the 2024 plan year.

Feb 9, 2023, 09:11 by Molly McGrath

Feb 9, 2023, 08:34 by Molly McGrath

Rockville, MD – The American Society of Addiction Medicine (ASAM) today released a “Public Policy Statement on Racial Justice Beyond Health Care: Addressing the Broader Structural Issues at the Intersection of Racism, Drug Use, and Addiction,” the final public policy statement in a three-part series on advancing racial justice in the context of addiction medicine.

Feb 8, 2023, 12:23 by ASAM Weekly Editors

Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States.

Feb 8, 2023, 12:11 by Molly McGrath